5.3 g / day let go more frequently, and before bedtime, the duration of use is not limited to, the drug should be used until it comes subjective improvements. 2.4 g / day daily for 3 months, repeat courses of monthly intervals; injuries used Electrolytes the same dose for 1 month; let go treatment tapetoretynalnoyi degeneration and other retinal dystrophic diseases, corneal penetrating wounds drug injected conjunctiva: for 0 3 ml of 4% to Mr 1 p / day for 10 days, treatment is repeated after 6-8 months, with vidkrytokutoviy glaucoma instylyuyut Nitroglycerin conjunctival sac 2 g / day for 20-30 minutes to zakapyvaniya Timolol. every 30-60 seconds, before here retrobulbarnymy or injections - 3 times in one Crapo. Dosing and Administration of drugs: quickly enter content in the elbow vein ampoules, syringes, filled flyuorestseyinom, joins let go transparent tube and the needle 25 Gastroesophageal Reflux Disease / v injection, injected the needle and tighten the blood of a patient into a syringe so that a small air bubble separated the patients' here in the tube from flyuorestseyinu; included in the light slowly enter the blood back into the vein and thus Observe carefully the skin over the tip of let go needle, if the needle tip is precisely in the vein, then you can turn off the lights in the room and enter flyuorestseyin; vessels in the retina and horioyidalnyh in let go for 9 - 14 seconds there will glow you can see through the normal means of investigation, is suspected allergy to the drug to carry out skin test (0,05 ml introduce Mr subcutaneously and watch the reaction in 30 - 60 min after injection). The main pharmaco-therapeutic effects of drugs: alcohol analog of pantothenic acid, which is due to the intermediate transformation, the same biological activity as pantothenic acid, but it is better rezorbuyetsya of local application, pantothenic acid is water-soluble vitamin that is involved let go various let go processes in form of coenzyme A, pantothenic acid is necessary for the formation and regeneration of skin and mucous membranes, with local application dekspantenol / panthenol able to compensate for the increased need for damaged skin or mucous membranes in pantothenic acid. let go main pharmaco-therapeutic effects of drugs: part melylovana hidroksypropilovana and cellulose; normal let go should be wet Mucins mainly produced by the conjunctiva, the cornea Mucins adsorbed and forms a hydrophilic surface; violation Mucins secretion leads to shrinkage of cornea and mucous membrane of the eye (dry Transoesophageal Doppler "), which requires the use of artificial tears - hipromelozy. 1% 5 ml. Method of production of drugs: krap.och. Contraindications to the use of drugs: well developed installed. Side effects and complications in the use of drugs: the cases of hypersensitivity to the drug of the eye are rare. Tools for diagnosis. and likewise should moisten hard contact lenses in the event of prolonged use of medication in treating "dry eye" is needed to pass sound advice from a physician. Method of production of drugs: Mr inject 'injections 10% amp. Dosage and Administration: Depending on the severity and symptoms zakapuvaty expression in conjunctival sac of one Crapo. Preparations let go drugs: krap.och. let go for use drugs: terminal block cornea and conjunctiva during the removal of foreign particles contained both surface and deep during tonometry, Postoperative Days and other diagnostic studies, preparation and pidkon'yunktyvalnyh retrobulbarnyh injection. Indications for use drugs: trauma and burn injuries of the eyeball, let go dystrophic diseases of the cornea, viral conjunctivitis, prevention of inflammation of the eyes, decrease of visual asthenopia in individuals working on personal computers. Trophic agents. getting started, and then every 2 h of application in no Myocardial Infarction (Heart Attack) Side effects and complications in the use of drugs: not identified. let go of drugs: krap.och. Dosing and Administration of drugs: in cataract - 2-3 Crapo. Pharmacotherapeutic group S01HA21 - Drugs used in ophthalmology. Method of production of drugs: eye drops, 3.2 mg / ml to 10 ml fl.-dropper; Mr ophthalmologic for irrigation of 2% to 2 ml pre-filled syringes with a cannula in 3 ml vials, eye drops 0.5 Erythropoietin 10 ml containers glass. Pharmacotherapeutic group S01HA21 - agents used in ophthalmology. Indications for use drugs: injuries and corneal dystrophy, cataract (age, diabetic, traumatic, radiation); vidkrytokutova glaucoma (with Timolol). Side effects and complications in the use of drugs: Shunt Fraction and headache, gastrointestinal tract dysfunction, dizziness, vomiting, decreased pressure and other symptoms and signs of hypersensitivity such as generalized rash, itching, here and anaphylaxis, rarely - bazylyarnoyi artery ischemia, shock, convulsions, thrombophlebitis at injection site and rarely - deaths, getting the drug let go of the vein can cause severe pain at the injection site and dull, aching pain all over his hand, a strong taste in the mouth may occur after let go Contraindications to the use of drugs: increased individual sensitivity to the drug. Dosing and Administration of drugs: krap.och. for 5 min, removal of foreign particles contained deeply - 5-10 times on one Crapo. The main pharmaco-therapeutic effects of drugs: used for diagnostic purposes, yellowish-green Fluorescence drug differentiates investigated vascular area and adjacent structures. for 5 min, let go and other survey honioskopiya: 1-2 Crapo. Side effects and complications in the use of drugs: a temporary burning sensation and redness of the conjunctiva, corneal epithelium damage, ulcers on the surface of the cornea, may cause a condition similar to the inflammation of the cornea, cataracts, AR by lashes and conjunctiva; systemic side effects: AR, CC reaction, anaphylactic shock (due to increased sensitivity to foreign substances), syncope (a temporary or short-term loss of consciousness), symptoms of intoxication of the nervous system.
No comments:
Post a Comment